Half of the budget will go toward product development and the other $50 million is set aside for “a California-based insulin manufacturing facility that will provide new, high-paying jobs and a stronger supply chain for the drug,” Mr. Newsom said.
About a million state residents who have diabetes can’t afford the insulin they need, and across the nation, 1.2 million people “experienced catastrophic spending” after the treatment’s prices hiked more than 200 percent from 2008 to 2017.
“We know people should not go into debt to receive life-saving medication,” Mr. Newsom said. The budget allows California to manufacture “insulin at a cheaper price, close to at cost, and to make it available to all.”
The governor did not specify how much the insulin would cost.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.